Two Sigma Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Two Sigma Investments’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,000	Closed	-$226K	–	3780
2020 Q2	$226K	Buy	+5,000	New	+$224K	﹤0.01%	2569
2019 Q4	–	Sell	-8,700	Closed	-$354K	–	4192
2019 Q3	$354K	Buy	8,700 +900	+12%	+$38.9K	﹤0.01%	2830
2019 Q2	$376K	Buy	+7,800	New	+$410K	﹤0.01%	2711

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Two Sigma Investments's BEAT Position: Q4 2019 in Review

Two Sigma Investments sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 5,363 shares — an estimated $232K sold.

Two Sigma Investments first reported a position in BEAT in Q2 2015 and held it in 13 quarters. The position peaked at $7.48M in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

Two Sigma Investments reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
Two Sigma Investments sold 5,363 BioTelemetry, Inc. shares in Q4 2019, an estimated $232K.
Two Sigma Investments first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 13 quarters.
Two Sigma Investments's BioTelemetry, Inc. position peaked at $7.48M in Q1 2019.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.